Keywords: India, Reference pricings, Patented drugs, Per-capita income, OPPI

Indian linkage of drug reference pricing to per capita income could reduce patent medicine prices

Article | 19 August 2012

In India, an inter-ministerial group formed in 2007 and tasked with regulating prices of patented drugs has recommended using a per ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in